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Global Regulation of Germline Genome
Editing:
Ethical Considerations and Application of
International Human Rights Law
SCOTT J. SCHWEIKART*
I. INTRODUCTION
Genome editing is a biomedical tool that can make “precise alterations, additions, [and] deletions” to an organism’s genetic makeup.1 In
2018, the world was shocked by the birth of twin girls in China,2 the first
children to have their genomes modified by the powerful new gene-editing tool, CRISPR. The news was crucial for two reasons: (1) the alterations to the twin girls’ genomes was a form of germline genome editing,
meaning their genetic modifications are heritable; and (2) CRISPR was a
new gene-editing tool known for its revolutionary precision, ease of use,
and cost. CRISPR technology possesses potential to be far reaching and
broad in its impact; it can be used for human germline modification,3 as
* Senior Research Associate at the American Medical Association and Legal Editor of the AMA
Journal of Ethics. M.B.E., University of Pennsylvania; J.D., Case Western Reserve University;
B.A., Washington University in St. Louis. I would like to thank Professor Cesare Romano for inviting me to Loyola Law School, Los Angeles to participate in their symposium “The Challenge
of the Creation of a Global Regulation Regime for Human Germline Genome Modification”.
Also special thanks to my colleague Sean McConnell for helpful conservations and feedback.
1. NAT’L ACADS. OF SCIS., ENG’G, & MED., HUMAN GENOME EDITING: SCIENCE, ETHICS,
AND GOVERNANCE 1 (The National Academies Press 2017), https://doi.org/10.17226/24623. This
report is an excellent introduction to genome editing and offers a terrific summation of the technology, key governance, and ethical principles at play.
2. Julia Belluz, Is the CRISPR Baby Controversy the Start of a Terrifying New Chapter in
Gene Editing?, VOX (Jan. 22, 2019, 12:40 PM), https://www.vox.com/science-and-health/2018/11/
30/18119589/crispr-gene-editing-he-jiankui; Antonio Regalado, Exclusive: Chinese Scientists are
Creating CRISPR Babies, MIT TECH. REV. (Nov. 25, 2018), https://www.technologyreview.com/s
/612458/exclusive-chinese-scientists-are-creating-crispr-babies/.
3. David Baltimore et al., A Prudent Path Forward for Genomic Engineering and Germline
Gene Modification, 348 SCI. 36, 36-37 (2015) (“CRISPR-Cas9 technology, as well as other genome
engineering methods, can be used to change the DNA in the nuclei of the reproductive cells that
transmit information from one generation to the next [i.e., an organism’s germline].”).
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well as for somatic cell modification. Hence, questions and concerns
about the ethics and governance of genome editing are now abound in the
legal and bioethical discourse.
Because of the global nature of the consequences that genome editing can and will yield, particularly from the perspective of germline genome editing, a global form of governance should be considered. International human rights law provides a logical place to look for such
governance because the consequences involve human rights matters, the
nature of which covers the profound ethical implications that stem from
germline genome editing (i.e., ethical implications most notably relating
to principles of autonomy and justice which are linked to the essence of
human rights).
This essay explores the linkages of bioethics and international human rights law in the context of genome editing, by first giving a brief
introduction to genome editing technology, then an examination into the
ethics of genome editing (drawing a distinction between somatic and
germline genome editing), and closing with a discussion of the various
forms of international human rights law (and their limitations) relevant to
the bioethics of germline genome editing.
II. HUMAN GENOME EDITING: TECHNOLOGIES AND TECHNIQUES
To begin this discussion, a brief synopsis of genome editing—a description of the technology and how it functions—is useful. Before the
advent of the now-popularized CRISPR (short for clustered regularly interspaced palindromic repeats4), the chief genome editing tools relied on
these primary nucleases5: meganucleases, zinc-finger nucleases (ZFNs),
and transcription activator-like effector nucleases (TALENs).6 These nucleases are effective genome editors, but they are “technically challenging, time-consuming, and expensive,” as researchers are required to design ZFNs and TALENs that will be site-specific. That is, researchers
have to design the proteins to bind to the spot of DNA that they want to
cut or edit.7 ZFNs and TALENs are not a favored genome editing tool
because they are “expensive, technically challenging, and time-consuming,” and require protein engineering to target specific DNA sequences.8

4. NAT’L ACADS. OF SCIS., ENG’G, & MED., supra note 1, at 65.
5. Nucleases are enzymes that biochemically cleave DNA molecules. See id. at 62-63.
6. Id. at 63-64.
7. Id. at 65.
8. Arthur L. Caplan et al., No Time to Waste—the Ethical Challenges Created by CRISPR,
16 EMBO REPS. 1421, 1421 (2015).
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The discovery of CRISPR was monumental because CRISPR is
much more precise, less expensive, and less time consuming compared
to previous genome editing tools.9 Indeed, “[t]he key distinguishing feature” between CRISPR and tools like TALENs and ZFNs “is that
[CRISPR] uses RNA sequences instead of protein segments to recognize
specific sequences in the DNA,”10 thus allowing CRISPR to have greater
precision. CRISPR was initially discovered to be a function of a bacteria’s immunity against viruses; a discovery that “represents a major conceptual advance in its own right.”11 To edit a genome using CRISPR,
a Cas9 protein [a type of nuclease12] along with a CRISPR
“guide RNA” can find a target gene among the thousands of
genes in a cell’s genome and cleave both DNA strands at the
target site. It is this cleavage event that can be exploited to create
a mutation in, or “edit,” the target gene.13
CRISPR can broadly employ two kinds of edits: Non-Homologous
End Joining (NHEJ), which is an effective way to deactivate a gene; and
Homology Directed Repair (HDR), which can help process a “gene replacement” type of edit. NHEJ involves a Cas9 protein essentially cutting
the DNA and then the cut ends join together; this process “often deletes
a few bases, which may cripple the gene product, or cause a frameshift
that inactivates [the gene].”14 By contrast, HDR will “repair the damaged
allele [i.e., an allele cleaved by Cas9] using another piece of DNA with
homology to the target,”15 which will delete and insert genetic material
(a “gene replacement”) into the genome.
9. HENRY T. GREELY, THE END OF SEX AND THE FUTURE OF HUMAN REPRODUCTION 180
(Harvard Univ. Press ed. 2016) (“Like cars before the Model T, other genome editing methods
existed earlier [e.g., ZFNs, TALENs], but they were expensive, difficult, and, as a result, not commonly used. With CRISPR/Cas9, cheap, easy, and fast genome editing is now available, like the
Model T was, to everyman—or at least everyone with molecular biology training and a few thousand dollars.”).
10. NAT’L ACADS. OF SCIS., ENG’G, & MED., supra note 1, at 65.
11. Id. at 222. This point often gets overlooked in recent discussions about CRISPR technology, especially in the popular media. The amazing biochemistry of how CRISPR-Cas9 naturally
functions as an immunity tool is an impressive and intricate mechanism; as Carl Sagan once said,
an example of “the awesome machinery of nature.”
12. Cas is short for “CRISPR-associated.” Cas proteins are a type of nuclease, i.e., “a class of
proteins that facilitate chemical reactions” that will “cut DNA.” See John M. Conley, Introduction:
A Lawyer’s Guide to CRISPR, 97 N.C. L. REV. 1041, 1044 (2019).
13. Kelly E. Ormond et al., Human Germline Genome Editing, 101 AM. J. HUM. GENETICS,
167, 168 (2017).
14. Devashish Rath et al., The CRISPR-Cas Immune System: Biology, Mechanisms, and Applications, 117 BIOCHIME 119, 126 (2015) (presenting an instructive scientific explanation for how
the CRISPR-Cas system functions).
15. Id.
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Critically, there are noted frequent errors with CRISPR, such as off
target changes to the genome and mistakes where parts of DNA are
wiped-out or rearranged.16 We are in the early stages of this technology,
so safety risks remain.17 In fact, there are concerns of unknown side effects that may not necessarily be harmful,18 but do carry inherent risks
with a full range of consequences that are unknown in scope.
Techniques for implementing genome editing technologies typically
involve either ex vivo (outside the body) or in vivo (in the body) methods.19 Ex vivo methods involve removing the “target cell population . . .
from the body, [which are] modified with programmable nucleases and
then transplanted back into the original host.”20 In vivo genome editing is
a “direct delivery of programmable nucleases to disease affected cells in
their native tissues.”21 A viral vector is often used to deliver the nucleases
(e.g., CRISPR-Cas9) to the targeted cell’s nucleases.
III. ETHICAL ANALYSIS OF HUMAN GENOME EDITING
Before diving into the ethics of genome editing, it is important to
first understand the key distinctions between somatic and germline genome editing. Notably, the heritable nature of germline genome editing
as opposed to the individualistic nature of somatic genome editing has
profound relevance in any ethical analysis because of the divergent potential consequences.

16. Ricki Lewis, Is CRISPR Gene Editing Doomed, Even as Gene Therapy Enters the Clinic?,
DNA SCI. BLOG (Aug. 9, 2018), https://blogs.plos.org/dnascience/2018/08/09/is-crispr-gene-editing-doomed-even-as-gene-therapy-enters-the-clinic/ (noting a recent study showing a “mess of
missing and moved chromosome parts in the wake deploying the famed ‘molecular scissors’ [i.e.
CRISPR]”); Brad Plumer et al., A Simple Guide to CRISPR, One of the Biggest Science Stories of
the Decade, VOX (Dec. 27, 2018), https://www.vox.com/2018/7/23/17594864/crispr-cas9-geneediting (“Cas9 enzymes can occasionally ‘misfire’ and edit DNA in unexpected places, which in
human cells might lead to cancer or even create news diseases.”).
17. Lewis, supra note 16 (noting that while there are harmful side effects of CRISPR being
discovered now, in the long term these issues will be worked out, i.e. “[t]he unexpected genomic
damage is simply a problem to be solved”).
18. Antonio Regalado, China’s CRISPR Twins Might Have Had Their Brains Inadvertently
Enhanced, MIT TECH. REV. (Feb. 21, 2019), https://www.technologyreview.com/s/612997/thecrispr-twins-had-their-brains-altered/ [hereinafter China’s CRISPR Twins] (noting that with regard
to the now famous “CRISPR twins” in China, “new research shows that the same alteration introduced into the girls’ DNA, to a gene called CCR5, not only makes mice smarter but also improves
human brain recovery after stroke, and could be linked to greater success in school”).
19. David Benjamin Turitz Cox et al., Therapeutic Genome Editing: Prospects and Challenges, 21 NATURE MED. 121, 126 (2015).
20. Id. at 126.
21. Id.
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A. Somatic vs. Germline Genome Editing
Somatic genome editing involves editing an individual’s cells in a
part of their body, rather than the germline. Some potential therapeutic
uses of CRISPR for somatic-based treatments may range from “cancer
immunotherapy, to treating infectious diseases, to creating stem cell models of disease.”22 For example, CRISPR has the potential to treat diseases
like sickle cell,23 and CRISPR gene therapy trials in China show potential
to treat cancer and HIV by editing the genomes of immune cells.24 Hence,
there is great promise of therapeutic somatic cell treatments; however,
some scholars and bioethicists have concerns that such edits may be “enhancements” and not merely therapeutic measures.
Germline genome editing (also sometimes referred to as heritable
genome editing) refers “to all manipulations of germline cells,” which
include primordial germ cells, gametes, zygotes and embryos.25 CRISPR
technology can affect the germline of subsequent generations via a tool
called a gene drive.26 A “gene drive actively copies a mutation made by
CRISPR on one chromosome to its partner chromosome and thereby ensures that all offspring and subsequent generations will inherit the edited
genome.”27 While discussion of gene drives often center around their use
in insects (such as mosquitos), they can potentially be used in humans as
well.
Additionally, there is a significant level of uncertainty about the
safety and potential consequences of germline genome editing. For instance, it is uncertain “whether current knowledge of human genes, genomes, and genetic variation and the interactions between genes and the
environment is sufficient to enable heritable genome editing to be performed safely.”28

22. Caplan et al., supra note 8, at 1425.
23. Gina Kolata, These Patients Had Sickle-Cell Disease. Experimental Therapies Might
Have Cured Them., N.Y. TIMES (Jan. 27, 2019), https://www.nytimes.com/2019/01/27/health
/sickle-cell-gene-therapy.html. The patients discussed in this article were not treated using CRISPR
technology, but the article notes that CRISPR has potential for future use as a gene therapy in this
realm.
24. Kathryn Ellen Foley, Chinese Scientists Used Crispr Gene Editing on 86 Human Patients,
QUARTZ (Jan. 23, 2018), https://qz.com/1185488/chinese-scientists-used-crispr-gene-editing-on86-human-patients/.
25. NAT’L ACADS. OF SCIS., ENG’G, & MED., supra note 1, at 111 n.1.
26. Caplan et al., supra note 8, at 1422 (“Gene drive is a powerful tool that makes it more
likely that the edited trait will be passed on to offspring through sexual reproduction.”).
27. Id. at 1422. See Id. at 1423 Figure 1 for a useful diagram demonstrating a gene drive.
28. NAT’L ACADS. OF SCIS., ENG’G, & MED., supra note 1, at 118.
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B. Ethical Considerations
Tom Beauchamp and James Childress29 famously outlined the bioethical principles of autonomy, non-maleficence, beneficence, and justice;30 all of which are relevant and should be evaluated when considering
the ethics of germline genome editing.
1. Autonomy
The ethical principle of autonomy is focused on issues of an individual’s liberty, privacy, choice, and freedom of will.31 Issues of autonomy are relevant to both somatic and germline genome editing. In the
case of somatic genome editing, autonomy is key in terms of an individual’s desire to do what they want for their own body, whether that is therapeutic treatment or enhancement. In regard to germline genome editing,
the concept of autonomy is particularly relevant when considering future
generations of “individuals who will be affected by the present intervention.”32 Here, these individuals’ informed consent cannot be reached, and
hence their autonomy is arguably contravened; future generations of
those with germline edits have no say in the previous modifications to
their present genome. Some, like Ruth Macklin, have argued that such an
autonomy argument is a “red herring” and note that “the fact that they
[future generations] did not—and could not—consent to being protected
in that way does not demonstrate that their autonomy was somehow violated. Their autonomy is not yet in existence, so there is nothing to be
violated.”33 However, others have raised this concern about the right of
“future generations to be free of genetic alterations made without their
consent.”34 Alta Charo notes that the “concern here is that a child [born
with a germline edited modified genome] might feel less unique or less
free simply by knowing that some of his or her traits were chosen by
someone else,” and that such could be violative of individual rights “to
the extent that human rights are founded on notions of autonomy and dignity.”35 At the same time, concern for autonomy also comes into view for
29. TOM L. BEAUCHAMP & JAMES F. CHILDRESS, PRINCIPLES OF BIOMEDICAL ETHICS (4th
ed. 1994).
30. Id. at 120, 189, 259, 326.
31. Id. at 120.
32. Ruth Macklin, Applying the Four Principles, 29 J. MED. ETHICS 275, 279 (2003).
33. Id.
34. Maha F. Munayyer, Genetic Testing and Germ-Line Manipulation: Constructing a New
Language for International Human Rights, 12 AM. U. J. INT’L L. & POL’Y 687, 698 (1997).
35. R. Alta Charo, Germline Engineering and Human Rights, 112 AJIL UNBOUND 344, 346
(2018). Note that the notion of autonomy and its impact on human dignity is critical; the linkage of
autonomy and human dignity is one of the key bridges of bioethics to human rights law.
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parents who may desire to have their child born free of a certain disease,
or born with an enhancement they desire. Hence, autonomy of both parents and future children must be considered with respect to concerns
about ethical autonomy and germline genome editing.
2. Non-maleficence and Beneficence
The ethical principle of non-maleficence is essentially a duty to “do
no harm,”36 and the principle of beneficence is the obligation to “act for
the benefit of others.”37 These principles require a weighing of the degree
in which such actions cause harm or help society; such a weighing of
harms and benefits are appropriate for both somatic and germline genome
editing technology. Implicit in the weighing of the consequences of genome editing (both at the somatic and germline levels) is the question of
whether the given modification is a therapeutic treatment or enhancement. This distinction is important and often there is no clear line between
the two. “Enhancement is commonly understood to refer to changes that
alter what is ‘normal,’”38 but what is “normal” or “natural” is certainly
debatable.39
A large component of the ethical debate concerning the “good” and
“bad” consequences (relevant to both somatic and germline genome editing) is the concept of “genetic essentialism.”40 Genetic essentialism is
the notion that “genes alone account for who humans are” or that “genetics is the foundation of human nature.”41 Sometimes this notion of essentialism suggests a flawed argument for over-regulation of genome editing; this relates especially to whether genome editing involves
enhancement or treatment because enhancement is often viewed as
changing the “foundation of human nature.”42 The Nuffield Council on
Bioethics, however, rejects the notion of an emphasis on genetic
36. BEAUCHAMP & CHILDRESS, supra note 29, at 189.
37. Id. at 260.
38. NAT’L ACADS. OF SCIS., ENG’G, & MED., supra note 1, at 138.
39. The question of enhancement is complex and nuanced. For an excellent discussion on the
nature of enhancement, see I. Glenn Cohen, What (If Anything) is Wrong With Human Enhancement? What (If Anything) is Right With It?, 49 TULSA L. REV. 645, 685-86 (2014) (“While bioethicists and lawyers talk about “enhancement” with some frequency, the borders of the concept are
not well defined. Moreover, enhancements are not all homogenous, so it would be very foolish to
try to take a singular position on “enhancement.”).
40. Eli Y. Adashi & I. Glenn Cohen, The Ethics of Heritable Genome Editing: New Considerations in a Controversial Area, 320 JAMA 2531, 2531 (2018).
41. Id. Genetic essentialism is an idea often found in the popular culture which rests on the
theory that genetics determines everything. This idea is of course not accurate; however, emphasis
on genetic essentialism is often persuasive to the general public.
42. Id.
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essentialism, noting that doing so “seems incoherent since the human genome is not a single, stable thing, nor is it distinct in particular from the
genomes of other organisms.”43
In addition, the weighing of the “good” and “bad” in the context of
germline genome editing can yield a “precautionary principle,” where an
emphasis of caution is placed on possible negative outcomes. For example, “the extreme caution that individual geneticists and scientific organizations have expressed regarding the unknowns, uncertainties, and potential dangers of germline interventions suggest that precautionary
principle may always be operative in this line of biomedical research [i.e.
germline modification].”44
3. Justice
The ethical principle of justice is derived from concepts of what is
fair and equitable.45 Issues of justice are of concern for both somatic and
germline genome editing. Consider the example of germline genome editing that would confer a benefit (such as a modification to help confer
immunity):46 if such an “enhancement is available only to the upper classes, it can further widen the already existing gap between the more advantaged and less advantaged members of society and thus exacerbate
injustices.”47 Ethically, the “benefits of heritable genome editing should
not preferentially accrue only to the affluent individuals.”48 Indeed, there
is a human rights aspect with regard to social justice, as “[t]he potential
for discrimination against genetic groups increases dramatically as genetic testing and [germline manipulation] techniques become less
43. NUFFIELD COUNCIL ON BIOETHICS, GENOME EDITING AND HUMAN REPRODUCTION 92
(2018), http://nuffieldbioethics.org/wp-content/uploads/Genome-editing-and-human-reproduction
-FINAL-website.pdf.
44. Macklin, supra note 32, at 279. Macklin is skeptical about apportioning too much caution
to uncertain negative consequences. Macklin notes that, “much less plausible are the negative consequences envisaged by opponents of germline interventions,” and that giving voice to a “litany of
potential negative consequences” is “another illustration of opponents of a proposed action or policy inventing a fanciful array of worst case scenarios in seeking to demonstrate that the potential
harms far outweigh the likely benefits.”
45. BEAUCHAMP & CHILDRESS, supra note 29, at 327.
46. Macklin, supra note 32, at 278. There may be some dispute about whether a modification
to give immunity to HIV would be an enhancement or more in line with a therapeutic treatment.
Because it is a modification that is “health related,” Macklin notes that, “since disease prevention
is a central function of medicine and public health, enhanced protection against disease has not
been questioned by opponents of other types of enhancement,” thus underscoring the debate that
takes place around what is or is not an “enhancement” may hinge on whether or not the proposed
modification had some medicinal benefit.
47. Id. at 279.
48. Adashi & Cohen, supra note 40, at 2531 (referencing the Nuffield Council recommendation).
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expensive, more reliable, and more widely available.”49 Maha Munayyer
explains that “[germline manipulation] provoke[s] discrimination based
on genetic status while simultaneously providing the means to alter that
status.”50 An additional concern is that the price of the technology is yet
another way that inequality may spread, as “editing is likely to be expensive” and “[g]enetic disease, once a universal common denominator,
could instead become an artifact of class, geographic location, and culture.”51
IV. INTERNATIONAL HUMAN RIGHTS LAW
Considering the multiple ethical issues germane to genome editing—particularly that of the germline and its consequential potential—,
questions surface as to what the best ways are to regulate or police such
biotechnology to ensure ethical practice. International human rights law
is a natural place to look for such a regulatory mechanism, in large part
because of the linkage of bioethics and human rights.52 Indeed, legal
scholars have noted that “at the beginning of the twenty-first century bioethics and human genome modification started being discussed within
the wider international human rights framework and the even wider international law framework.”53 The consequential power to shape humanity, as germline genome editing possesses, arguably makes the technology prime to fall under the jurisdiction of human rights law, as
“[m]embership in the human species is central to the meaning and enforcement of human rights.”54 Recognizing the implicit linkage of human
49. Munayyer, supra note 34, at 719.
50. Id. at 720-21 (“At the very least, gene manipulation can create the social perception that
genetic conditions are within human control, weakening the argument for protected status.”).
51. Ormond et al., supra note 13, at 172.
52. Richard E. Ashcroft, Could Human Rights Supersede Bioethics?, 10 HUM. RTS. L. REV.
639, 639-40 (2010) (noting the relationship between bioethics and human rights “are two assemblages of concepts, practices and institutions which take a profound interest in, and exert considerable influence over, the practice of medicine, health policy and the life sciences and technologies”).
53. CESARE P.R. ROMANO, ANDREA BOGGIO, & JESSICA ALMQVIST, Chapter 2: The Governance of Human (Germline) Genome Modification at the International and Transnational Level,
in HUMAN GERMLINE GENOME MODIFICATION AND THE RIGHT TO SCIENCE: A COMPARATIVE
STUDY OF NATIONAL LAWS AND POLICIES, CAMBRIDGE UNIVERSITY PRESS 22 (Andrea Boggio,
Cesare P.R. Romano, Jessica Almqvist eds., 2019) Authors note the relationship of international
human rights law with regards to the governance of germline genome editing: “[g]overnance of
human germline genome modification is a crucial but narrow facet of the larger question of the
governance of human genome modification tout court, which, in turn, is a subset of a broader field,
international bioethics law, which is itself a specialized branch of international law.” Id. at 31.
54. George J. Annas, Lori B. Andrews & Rosario M. Isasi, Protecting the Endangered Human: Toward an International Treaty Prohibiting Cloning and Inheritable Alterations, 28 AM. J.
L. & MED. 151, 153 (2002) (explaining that, “if we take human rights and democracy seriously, a
decision to alter a fundamental characteristic in the definition of “human” [i.e., such an alteration
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rights and the regulation of human genome editing, Andrea Boggio and
other scholars stress that “[i]nternational human rights standards should
be central to the development of germline engineering law” as some “national regulatory approaches” to the technology “fail to meet human
rights standards.”55
The Universal Declaration of Human Rights, established by the
United Nations (UN) in 1948, is the seminal document in international
human rights law and enshrines broad human rights principles.56 The declaration is given effect and is more specifically addressed through nine
core international human rights treaties: e.g., the International Convention on the Elimination of All Forms of Racial Discrimination, the International Covenant on Civil and Political Rights, and the Convention on
the Rights of the Child.57 The declaration “sets out a list of principles that
play an important role in bioethics,” including such principles as the right
to health care, prohibition on discrimination, protection of privacy, and
right to life.58
Following the advent of the declaration, international human rights
turned more specially to bioethics through a few key conventions and
declarations—most notably Europe’s European Convention of Human
Rights and the United Nations Educational, Scientific and Cultural Organization’s (UNESCO) series of bioethics declarations—all of which
are relevant to influencing germline genome editing.

that heritable genetic alteration is capable of accomplishing] should not be made by any individual
or corporation without wide discussion among all members of the affected population”).
55. Andrea Boggio, Barth M. Knoppers, Jessica Almqvist, & Cesare Romano, The Human
Right to Science and the Regulation of Human Engineering, 2 CRISPR J.,134, 134 (2019). The
authors say that
[n]o matter how technical or specific legislation regulating germline engineering is,
governments cannot depart from their international human rights obligations when developing regulatory frameworks. It is not just a matter of legality. It is a matter of
legitimacy. International human rights standards are the legal articulation of widely
agreed upon values. They are an expression of an internationally negotiated consensus.
56. G.A. Res. 217 (III) A, Universal Declaration of Human Rights, (Dec. 10, 1948), https://
www.un.org/en/universal-declaration-human-rights/.
57. The Core International Human Rights Instruments and Their Monitoring Bodies, UN
HUMAN RIGHTS OFFICE OF THE HIGH COMMISSIONER, https://www.ohchr.org/EN/Professional
Interest/Pages/CoreInstruments.aspx.
58. Roberto Andorno, Global Bioethics and Human Rights, 27 MED. & L. 1, 2 (2008) (noting
the Universal Declaration’s role in bioethics, and explaining how its preamble recognizes the principle of the “inherent dignity and of the equal and inalienable rights of all members of the human
family;” a principle broadly reflective of bioethical principles).
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A. Convention on Human Rights and Biomedicine (Oviedo Convention)
A key piece in the bioethics framework of international human
rights is the European Convention of Human Rights (known as the
Oviedo Convention).59 Produced by the Council of Europe, the convention is a legally binding document between signatory European states,60
codifying notions of bioethics into international human rights law.61 The
Oviedo Convention has particular relevance in international law, as it is
“not only the first, but still the only legally binding international treaty in
bioethics.”62 Article 13 of the Convention speaks directly to the issue of
genome modification, stating, “an intervention seeking to modify the human genome may only be undertaken for preventive, diagnostic or therapeutic purposes and only if its aim is not to introduce any modification in
the genome of any descendants.”63 The language clearly makes a distinction between genome editing for either therapeutic or enhancement purposes and favors genome editing for therapeutic purposes as an ethical
option. But it also goes further, prohibiting “any modification of germline
genes, whether for therapeutic or non-therapeutic aims.”64
In addition, the Oviedo Convention notably focuses on the protection of “human dignity,”65 mirroring the emphasis placed on human dignity displayed in UNESCO’s Declaration on the Human Genome and Human Rights (discussed below). The interplay of “human dignity” and its

59. EUR. CONSULT. ASS., Convention on Human Rights and Biomedicine (Oviedo Convention), 4th Sess., Doc. No. 164 (1997) [hereinafter Oviedo Convention], https://www.coe.int/en/web/
conventions/full-list/-/conventions/rms/090000168007cf98.
60. While many European countries are signatories, some key nations such as the U.K. and
Germany have not yet signed. See EUR. CONSULT. ASS., Committee on Bioethics, (May 17, 2019),
https://rm.coe.int/inf-2019-2-etat-sign-ratif-reserves-bil-002-/16809979a8 (chart of signatures and
ratifications).
61. Judit Sandor, Human Rights and Bioethics: Competitors or Allies? The Role of International Law in Shaping the Contours of a New Discipline, 27 MED. & L. 15, 17 (2008).
62. Peter Sykora & Arthur Caplan. The Council of Europe Should Not Reaffirm the Ban on
Germline Genome Editing in Humans, 18 EMBO REPS. 1871 (2017).
63. Oviedo Convention, supra note 59, at art. 13.
64. Sykora & Caplan, supra note 62, at 1871. Sykora and Caplan are critical of the Oviedo
Convention’s ban on germline editing and would prefer that the language be amended to further
distinguish between therapeutic and non-therapeutic editing purposes in both somatic and germline
editing. Currently, the language of Article 13 makes a distinction between somatic and germline
editing, the latter of which is banned regardless of purpose.
65. Sandor, supra note 61, at 18 (noting that the notion of “human dignity” emphasized in the
convention stems from French law and its value of human dignity in biomedicine); Francoise Baylis
& Lisa Ikemoto. The Council of Europe and the Prohibition of Human Germline Genome Editing,
18 EMBO REPS. 2084, 2084 (2017) (“[T]he Oviedo Convention, as currently worded, prioritizes
[and quite properly so, in their view] human rights and human dignity over scientific ambition and
the technological imperative.”).
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meaning in the context of germline modification, critically offers a window into the understanding of broader human identity.
B. UNESCO Declarations
Within the United Nations, the specialized agency known as
UNESCO has been “dealing with the ethics of science ever since 1970.”66
Since the 1990s, UNESCO has put forth multiple declarations in the
realm of bioethics,67 three of which are explored below.
1. Universal Declaration on the Human Genome and Human Rights
Another piece of international human rights doctrine directly relevant to genome editing is the Universal Declaration on the Human Genome and Human Rights.68 In 1997, UNESCO created the declaration,
which is composed of twenty-one articles, the first of which states, “the
human genome underlies the fundamental unity of all members of the
human family, as well as the recognition of their inherent dignity and
diversity. In a symbolic sense, it is the heritage of humanity.”69 The declaration’s focus is substantially on “human dignity” in connection with
practices involving the genome. While the declaration does not mention
germline modification specifically70 (rather it mentions human cloning71),
the broadness of the declaration’s language is inclusive of genome editing
technology.72 However, the declaration does “not have the direct force of

66. Sandor, supra note 61, at 16.
67. Id. at 17.
68. United Nations Educational, Scientific and Cultural Organization [UNESCO] Res. 29
C/Res. 16, (Nov. 11, 1997), http://portal.unesco.org/en/ev.php-URL_ID=13177&URL_DO=DO_
TOPIC&URL_SECTION=201.html.
69. Id. at Article 1. Note how the declaration links together the human genome with the notion
of human dignity, suggesting that the genome is fundamental to humanity’s essence.
70. See Tara R. Melillo, Gene Editing and the Rise of Designer Babies, 50 VAND. J.
TRANSNAT’L L. 757, 787-88 (2017). Tara Melillo argues that the declaration should be amended
to specifically add the language “such as germline genetic modifications” as an example of a practice contrary to human dignity, and thus impermissible under the declaration.
71. UNESCO 29 C/Res. 16, supra note 68, at art. 11.
72. Brooke Elizabeth Hrouda, “Playing God?”: An Examination of the Legality of CRISPR
Germline Editing Technology Under the Current International Regulatory Scheme and the Universal Declaration on the Human Genome and Human Rights, 46 GA. J. INT’L & COMP. L. 221, 233
(2017) ( “[The Declaration’s] articles establish that technology [i.e., technology associated with the
human genome] cannot overstep boundaries by interfering with the inherent right of human dignity.”).
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law”73 and merely serves as guidance for nations to pass laws that “prohibit those genetic practices that are contrary to human dignity.”74
The larger question thus becomes: what constitutes “human dignity?” One answer is that human dignity is “respect derived automatically
from one’s status as a human being.”75 Therefore, some scholars argue
that alterations to the genome for “enhancement” purposes is a type of
transhumanism that violates human dignity.76 Indeed, this line of thinking
supports the declaration as an ethical tool that can be used to protect
against violations of “human dignity” conducted via genetic alterations
meant to enhance a human being.77 As some scholars argue, violations of
human dignity via enhancement genome editing calls into question the
personhood status of individuals with an altered genome, thus yielding
profound implications on the rights and status of such individuals.78 This
is particularly acute under a theory of “personhood” that emphasizes biology and genetics as determinative. Such a worldview that “implicitly
assumes that the totality of human DNA is the source of a human essence”
will invariably harm “the biological legacy” of children with germline
modifications and risk “their entitlement to human rights and legal protections.”79 In other words, human rights protections may be in doubt because germline modified individuals could potentially be deemed as possessing a trans-altered personhood status, thus removing them from the
normative status entitled to such protections.
2. International Declaration on Human Genetic Data
As an extension of the 1997 Declaration discussed above,80
UNESCO enacted the International Declaration on Human Genetic Data

73. Id. at 223; see also Bridget Toebes, Sex Selection Under International Human Rights Law,
9 MED. L. INT’L 197, 207 (2008) (Toebes explains that declarations may be deemed “soft law”
instruments” which have “no strict legal obligation, yet there is a growing reliance upon these instruments [i.e., declarations] by lawyers and academics, which reinforces their legal status”).
74. Annas, Andrews & Isasi, supra note 54, at 171-72.
75. Hrouda, supra note 72, at 234.
76. Alexandra M. Franco, Transhuman Babies and Human Pariahs: Genetic Engineering,
Transhumanism, Society and the Law, 37 CHILD. LEGAL RTS. J. 185, 186, 187 n.24 (2017) (defining
transhumanism as “a genetically engineered human enhanced beyond baseline human capabilities).
77. Id. at 194 (observing how scholars Annas, Andrews and Isasi “espouse the idea that human
rights attach to some essential aspect of biological ‘humanity’ as a justification to oppose Transhumanism and germline genetic engineering technologies”).
78. Note that “personhood” and “human dignity” are linked concepts. See Hrouda, supra note
72, at 234, 241 ( “[H]uman dignity means at its core: the right to respect one’s individual personhood and uniqueness” and that human dignity “values individual personhood above all else.”).
79. Franco, supra note 76, at 201-02.
80. Andorno, supra note 58, at 4.
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in 2003.81 This declaration focused on the “rules for the collection, use
and storage of human biological samples” and the “genetic data” that can
be yielded from such collections.82 While this declaration deals with several bioethical principles (e.g., dignity, privacy, consent, discrimination),
particularly noteworthy is its treatment of identity:
Each individual has a characteristic genetic make-up. Nevertheless, a person’s identity should not be reduced to genetic characteristics, since it involves complex educational, environmental and personal factors and emotional, social, spiritual and
cultural bonds with others and implies a dimension of freedom.83
The declaration’s emphasis on identity is particularly interesting, especially in the context of genome editing and its propensity to alter an
individual’s genetic code. The language of the declaration appears to
push back against notions of genetic essentialism, viewing human identity as greater than the mere genetic make-up of an individual. Such a
view tends to support a notion of human dignity and identity for all individuals (or future generations), no matter how genetically altered they
may be for either therapeutic or enhancement purposes.
3. Universal Declaration on Bioethics and Human Rights
Another widely relevant UNESCO declaration is the Universal Declaration on Bioethics and Human Rights.84 UNESCO created this declaration in 2005 and it is “more general in character,” speaking to bioethical
principles more broadly.85 Indeed, it has been viewed as the “first intergovernmental global instrument that comprehensively addressed the linkage between human rights and bioethics.”86 It is similar to the Oviedo
Convention, in the sense that they both reflect broad bioethical principles
of autonomy, consent, privacy, and equitable access to health care.

81. United Nations Educational, Scientific and Cultural Organization [UNESCO] Res. 32
C/Res. 22 (Oct. 16, 2003), http://portal.unesco.org/en/ev.php-URL_ID=17720&URL_DO=DO_
TOPIC&URL_SECTION=201.html.
82. Andorno, supra note 58, at 4.
83. UNESCO 32 C/Res. 22, supra note 81, at art. 3.
84. United Nations Educational, Scientific and Cultural Organization [UNESCO] Res. 33
C/Res. 36 (Oct. 19, 2005), http://portal.unesco.org/en/ev.php-URL_ID=31058&URL_DO=DO_
TOPIC&URL_SECTION=201.html.
85. Toebes, supra note 73, at 209.
86. Andorno, supra note 58, at 4 (contemplating that the entire declaration “is conceived as
an extension of international human rights law into the field of biomedicine”) (emphasis omitted).
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C. Limitations of International Human Rights Law
There are significant limitations in using international human rights
law to govern the bioethical ramifications of germline genome editing.
The first is that creating a binding international treaty, with key nations
as signatories (e.g, China, U.S., U.K, Germany, India), is extremely difficult given the current (or truly any) political climate.87 Another challenge is that declarations (like the UNESCO declarations discussed
above) are non-binding, and therefore some argue that declarations are
the world’s best global governance option, as they are more feasible than
a binding treaty and have persuasive influence in the creation of normative conduct.88 In addition, because the enforcement of international human rights law is a recurring problem, some scholars argue that further
attempts to enforce such treaties are unproductive and recognize that human rights law is no longer in a “golden age.”89
There is also concern about how bioethical reasoning will find its
way into the realm of law, particularly because there is now a clear overlap of bioethics and law rooted in human rights. As Richard Ashcroft
notes, “there is no good reason to think that bioethical modes of reasoning
will be taken up by courts and policy-makers as tools of reasoning…in
contexts where the applications of rights-based reasoning is unclear, ambiguous or unhelpful [i.e, contexts where bioethics reasoning may help
resolve an ambiguity].”90
Additionally, it is important to consider how international law may
have limitations due to its potential inconsistency with an existing
87. Melillo, supra note 70, at 785 ( “[T]he current political climate hinders the likelihood of
negotiating such a treaty.”).
88. Id. at 788-89. Melillo reflects on the benefits of declarations versus treaties, explaining
that “a treaty would likely be unsuccessful at remedying the lack of an international consensus on
gene editing, but a declaration provides a solution far less adverse to a country’s autonomy” and
that “a declaration can indicate international consensus, absent the complexities and complications
necessary in drafting, enacting, and ratifying a treaty.”
89. See Ingrid Wuerth, International Law in the Post-Human Rights Era, 96 TEX. L. REV.
279, 279, 320-25, 349 (2017). In her article, Wuerth outlines the history of how human rights have
“expanded and changed international law in ways that have made it weaker, less likely to generate
compliance and more likely to produce interstate friction and conflict.” Wuerth illuminates how
enforcement of international human rights is nearly impossible in the modern era, as a result of a
historical record of non-compliance and unaccountability.
90. Ashcroft, supra note 52, at 659. Ashcroft further explains, “traditional modes of legal
reasoning, policy formation, and decision-making will not, and have no reason to, cede the field to
the methods of (academic) bioethics.” Here, Ashcroft reminds readers that while courts and policymakers may be taking up bioethical issues in the context of human rights law, they will likely still
use legal reasoning to make decisions, not the academic modes of reasoning traditionally used in
the field of bioethics. This could be considered a limitation on effectuating or merging bioethical
principles into human rights law.
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country’s national law. A prime example of this is when U.S. constitutional law competes with a human rights treaty; which law—the constitution or international law (e.g., a human rights treaty)—has supremacy
as applied to U.S citizens?91 This question would be relevant under circumstances where a human rights treaty may circumscribe a right guaranteed under constitutional law. An example of this could be a treaty that
functions as a moratorium on germline genome editing,92 which arguably
conflicts with constitutional rights of reproductive liberty. There is clear
constitutional precedent with regard to rights guaranteeing reproductive
liberty; note that a constitutional rights argument premised on privacy
and reproductive liberty is reflective of the bioethical principle of parental autonomy.93 However, it is important to remember that not all perspectives of autonomy will be the same world-wide (e.g., different cultures
will have different views on reproductive liberty). Such differences serve
as a reminder of another key limitation of human rights law: bioethical
principles are not uniform across the world and are strongly influenced
by culture.94 Hence, one set of global laws outlined in a single treaty or
declaration will invariably come into conflict when applied to individual
nations, as different cultures will have different sets of values and different understandings of bioethics and human rights.
Lastly, it is important to remember that any global governance structure that comes from a treaty or declaration is only intended to bind or
91. See Peter J. Spiro, Treaties, International Law, and Constitutional Rights, 55 STAN. L.
REV. 1999, 1999-2000 (2003). Spiro explores this notion of supremacy by asking the question:
“Can a treaty override an individual right protected under the Constitution?” In answering this
question, Spiro notes that while the long-standing doctrine of “Constitutional Hegemony” suggests
the constitution is supreme over a treaty, the reality is more complex, especially with the rise of
human rights in the canon of international law.
92. Debate about the necessity of an international moratorium on germline editing is currently
ongoing. While debate is spirited, consensus seems to be converging towards overall support of a
moratorium on germline editing; if an international treaty were to spring forth tomorrow, a moratorium on germline editing for reproductive and clinical purposes would likely be included. See
also Eric Lander et al., Adopt a Moratorium on Heritable Genome Editing, NATURE (Mar. 16,
2020), https://www.nature.com/articles/d41586-019-00726-5; Charo, supra note 35. See generally
Adashi & Cohen, supra note 40.
93. Annas, Andrews & Isasi, supra note 54, at 167 n.81. The authors note that, “[t]he right to
make decisions about whether or not to bear children is constitutionally protected under the constitutional right to privacy.” Right to privacy arguments about reproduction may extend to parents
asserting that they have the right to have the kind of child they want, i.e. a so-called “designer
baby”—a child whose genome is edited to their parents’desire.
94. David C. Thomasma, Proposing a New Agenda: Bioethics and International Human
Rights, 10 CAMBRIDGE Q. HEALTHCARE ETHICS 299, 302 (2001). Thomasma explains how notions
of autonomy vary in different cultures, noting how in some Western countries “the individual is
identified as the locus of decisional capacity for informed consent,” whereas the “very concept of
informed consent is almost meaningless in societies that stress the overriding importance of an
individual’s relationship with family and community.”
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influence individual nation-states, assuming that parties to such treaties
would use their own national legal framework to enforce relevant matters
in their jurisdiction. However, the relevant matters that national governments generally tackle are not always easily enforceable or identifiable
in this rapidly changing world of bio-medical advancements. For example, there is already a growing movement of DIY-Bio or “bio-hackers,”
who are buying CRISPR kits and are doing genetic modifications at
home, outside of the knowledge or purview of any government agency or
regulatory authority.95 Under such circumstances, even if a government
follows international human rights law to regulate germline genome editing, it may only have influence over the traditional users of biomedical
technology, i.e., corporations and university medical centers. No matter
how effective any form of international oversight may be, gaps will remain in policing the ethical practice of germline genome editing.
V. CONCLUSION
Recent events have provided impetus into both the ethical and governance analysis of genome editing. Issues of autonomy, non-maleficence, beneficence, and justice are all relevant and must be weighed. The
consequences of germline genome editing can be profound, even unpredictable and difficult to quantify at the moment; it may take many years
before the full consequences of certain heritable modifications are understood.96 As Jennifer Doudna, one of the key discoverers of CRISPR, cautions: “it’s important to recognize that we do now have the power to control evolution.”97
Looking to international human rights law as the face of governance
is logical; human rights (and the bioethical principles subsumed) are key
in providing guidance to humanity in the face of the new powers created
by scientific discovery. Indeed “[s]cience cannot tell us what we should
do, or even what our goals are, therefore, humans must give direction
[i.e., direction via human rights] to science.”98 Because the consequences
of germline genome editing are global in scale and affect all people, the
95. Nancy M. P. King, Human Gene-Editing Research: Is the Future Here Yet?, 97 N.C. L.
REV. 1051, 1080 (2019). King notes that the rise of CRISPR bio-hacking is an example of how
there is a “proliferation of regulatory and oversight mechanisms replete with gaps and overlaps.”
96. Amy Gutmann & Jonathan D. Moreno, Keep CRISPR Safe: Regulating a Genetic Revolution, 97 FOREIGN AFF. 171, 174 (2018) (noting that the reality is that it may take hundreds of
years to detect any changes) (“Unlike the generations of rapidly propagating species, such as mosquitos, human generations span many years, so any harmful change in a human germline could take
decades or even centuries to become pronounced.”).
97. Jennifer Doudna, The Ultimate Life Hacker, 97 FOREIGN AFF. 158, 164 (2018).
98. Annas, Andrews & Isasi, supra note 54, at 173.
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international structure of human rights law is appropriate. Conceding the
many limitations of international human rights law, it is, at its essence,
the correct body of law to help guide humanity through the challenges
raised by genome editing technology. Therefore, international human
rights deserve the focus and energy needed to make it a stronger and more
effective governance strategy for germline genome editing. Indeed, how
the concepts of human identity and human species are defined and understood in the future depends on our emphasis on international human rights
in the present.

